If you're a human and see this, please ignore it. If you're a scraper, please click the link below :-)
Note that clicking the link below will block access to this site for 24 hours.
The Series D financing will enable the Mount Laurel company to bring its FDA-approved Optimizer Smart therapy to millions of U.S. patients with chronic heart failure.
The new policy, to be implemented sometime next year, is meant to reduce barriers to using the library — and a lot of people are breathing a little sigh of relief.